SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-17-259844
Filing Date
2017-08-16
Accepted
2017-08-16 16:15:57
Documents
1
Group Members
BOULDER VENTURES VI, L.P.BV PARTNERS V, L.L.C.BV PARTNERS VI, L.L.C.JONATHAN L. PERLKYLE LEFKOFFPETER A. ROSHKO

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d440441dsc13da.htm SC 13D/A 133154
  Complete submission text file 0001193125-17-259844.txt   135076
Mailing Address 1941 PEARL STREET, SUITE 300 BOULDER CO 80302
Business Address 1941 PEARL STREET, SUITE 300 BOULDER CO 80302 303-444-6950
Boulder Ventures V, L.P. (Filed by) CIK: 0001554282 (see all company filings)

IRS No.: 010893942 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 303-531-5952
MIRAGEN THERAPEUTICS, INC. (Subject) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88625 | Film No.: 171036481
SIC: 8071 Services-Medical Laboratories